Brainomix
Oxford
About Brainomix
Since launching as a spin-out from the University of Oxford in 2010, Brainomix has developed award-winning, AI-powered imaging biomarkers, assisting physicians across the world to make better life-saving decisions. Brainomix seminal product, e-Stroke is a collection of tools that use state-of-the-art AI algorithms to support doctors by providing real-time interpretation of brain scans to help guide treatment and transfer decisions for stroke patients, allowing more patients to get the right treatment, in the right place, at the right time.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Total funding: $60.2M
- Funding stage: Late Stage Venture
- Last round: Series C (Feb 2026)
- Website: brainomix.com
- Phone: +44 (0) 1865 582730
Industries & Categories
Artificial Intelligence (AI), Biotechnology, Machine Learning, Medical, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/brainomix-102037 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.